NCT03011541 - Stem Cell Ophthalmology Treatment Study II | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions

Retinal DiseaseAge-Related Macular DegenerationRetinitis PigmentosaStargardt DiseaseOptic NeuropathyNonarteritic Ischemic Optic NeuropathyOptic AtrophyOptic Nerve DiseaseGlaucomaLeber Hereditary Optic NeuropathyBlindnessVision Loss NightVision Loss PartialVision, LowRetinopathyMaculopathyMacular DegenerationRetina Atrophy

Interventions

PROCEDURE

Arm 1

"Procedure/ Surgery: RB (Retrobulbar)~Retrobulbar injection of Bone Marrow Derived Stem Cells (BMSC)~Procedure/Surgery: ST (Subtenon)~Subtenon injection of Bone Marrow Derived Stem Cells (BMSC)~Procedure/Surgery: IV (Intravenous)~Intravenous injection of Bone Marrow Derived Stem Cells (BMSC)"

Trial Locations (4)

1010

RECRUITING

MD Stem Cells Kobinia Med, Vienna

33065

RECRUITING

MD Stem Cells, Coral Springs

06880

RECRUITING

MD Stem Cells, Westport

337-1500

RECRUITING

The Saudi-German Hospital, Dubai